SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001144204-19-030986
Filing Date
2019-06-14
Accepted
2019-06-14 16:05:42
Documents
10

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tv523445_s3.htm S-3 321448
2 EXHIBIT 4.3 tv523445_ex4-3.htm EX-4.3 365060
3 EXHIBIT 4.5 tv523445_ex4-5.htm EX-4.5 116680
4 EXHIBIT 4.6 tv523445_ex4-6.htm EX-4.6 118701
5 EXHIBIT 4.7 tv523445_ex4-7.htm EX-4.7 95645
6 EXHIBIT 5.1 tv523445_ex5-1.htm EX-5.1 29081
7 EXHIBIT 23.1 tv523445_ex23-1.htm EX-23.1 2648
8 GRAPHIC tv523445_ex5-1img01.jpg GRAPHIC 9477
9 GRAPHIC tv523445_img1.jpg GRAPHIC 21844
10 GRAPHIC tv523445_img2.jpg GRAPHIC 92769
  Complete submission text file 0001144204-19-030986.txt   1221881
Mailing Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027
Business Address 3200 SOUTHWEST FREEWAY SUITE 2240 HOUSTON TX 77027 (713) 400-6400
Marker Therapeutics, Inc. (Filer) CIK: 0001094038 (see all company filings)

IRS No.: 880277072 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-232122 | Film No.: 19898902
SIC: 2834 Pharmaceutical Preparations